VK-II-86
CAS No. 955371-84-3
VK-II-86( —— )
Catalog No. M25010 CAS No. 955371-84-3
VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 277 | In Stock |
|
| 10MG | 417 | In Stock |
|
| 25MG | 743 | In Stock |
|
| 50MG | 1115 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVK-II-86
-
NoteResearch use only, not for human use.
-
Brief DescriptionVK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity.
-
DescriptionVK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number955371-84-3
-
Formula Weight420.5
-
Molecular FormulaC25H28N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (237.81 mM)
-
SMILESCOC1=CC=CC=C1OCCNCC(CCOC2=CC=CC3=C2C4=CC=CC=C4N3)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gonano L A , Sepúlveda, Marisa, Morell M , et al. Non-β-Blocking Carvedilol Analog, VK-II-86, Prevents Ouabain-Induced Cardiotoxicity[J]. Circulation Journal, 2018.
molnova catalog
related products
-
Alamifovir PM
Alamifovir PM is an analogue of Alamifovir, an HBV-specific antiviral compound.
-
CITCO
CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49?nM over pregnane X receptor (PXR), and no activity on other nuclear receptors.
-
Mulberrofuran G
Mulberrofuran G shows moderate activity, inhibits hepatitis B virus (HBV) DNA replication with the IC(50) value of 3.99 μM.
Cart
sales@molnova.com